# A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PF-06842874 in Healthy Participants

> **NCT04124653** · PHASE1 · COMPLETED · sponsor: **Pfizer** · enrollment: 44 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** PF-06842874
- **DRUG:** Placebo
- **DRUG:** Relative Bioavailability

## Key facts

- **NCT ID:** NCT04124653
- **Lead sponsor:** Pfizer
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-17
- **Primary completion:** 2021-07-26
- **Final completion:** 2021-07-26
- **Target enrollment:** 44 (ACTUAL)
- **Last updated:** 2021-12-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04124653

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04124653, "A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of PF-06842874 in Healthy Participants". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT04124653. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*